Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients

Published:2011-10-12 Issue:1 Volume:12 Page:210-217
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Vincenti F.,Larsen C. P.,Alberu J.,Bresnahan B.,Garcia V. D.,Kothari J.,Lang P.,Urrea E. Mancilla,Massari P.,Mondragon-Ramirez G.,Reyes-Acevedo R.,Rice K.,Rostaing L.,Steinberg S.,Xing J.,Agarwal M.,Harler M. B.,Charpentier B.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2011.03785.x/fullpdf

Reference39 articles.

1. Renal dysfunction as a risk factor for mortality and cardiovascular disease in renal transplantation: Experience from the Assessment of Lescol in Renal Transplantation trial;Fellstrom;Transplantation,2005

2. Renal dysfunction is a strong and independent risk factor for mortality and cardiovascular complications in renal transplantation;Fellstrom;Am J Transplant,2005

3. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation;Meier-Kriesche;Transplantation,2003

4. Posttransplant renal function in the first year predicts long-term kidney transplant survival;Hariharan;Kidney Int,2002

5. United Network for Organ Sharing National Data 2011 http://www.unos.org/

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression in Kidney Transplant Recipients: An Update for the General Nephrologist;Advances in Kidney Disease and Health;2024-09

2. Belatacept based immunosuppression: What and when to combine?;Transplant Immunology;2024-08

3. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

4. Safety and Efficacy of Very Early Conversion to Belatacept in Pediatric Kidney Transplantation with Transplant-Associated Thrombotic Microangiopathy: Case Study and Review of Literature;Clinics and Practice;2024-05-16

5. Comparing the prognostic performance of iBOX and biopsy-proven acute rejection for long-term kidney graft survival;American Journal of Transplantation;2024-04